UCSF researchers examined the genetics of recurrent pregnancy loss, which affects about 5% of women. Their study pointed to genetic variants inherited from an often healthy parent. They hope their ...
Abeona Therapeutics is rated a Hold, as Zevaskyn uptake and manufacturing remain uncertain, and its $135 million cash ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results